FDA Drug Recalls

Recalls / Class II

Class IID-0660-2020

Product

Sumatriptan Succinate Tablets, 100 mg packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-69), Rx only, Sun Pharma, Cranbury, NJ

Affected lot / code info
JKT4174A, exp. date 11/2021 JKU0622A, exp. date 01/2022 JKU1308A, exp. date 02/2022

Why it was recalled

Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

Recalling firm

Firm
Sun Pharmaceutical Industries, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
270 Prospect Plains Rd, Cranbury, New Jersey 08512-3605

Distribution

Quantity
207,585 blisters
Distribution pattern
Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.

Timeline

Recall initiated
2019-12-26
FDA classified
2020-01-13
Posted by FDA
2020-01-22
Terminated
2020-10-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0660-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls